Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed

Erlangen, Germany |  Feb 03, 2020

Siemens Healthineers AG today announced its results for the first quarter of fiscal year 2020 that ended December 31, 2019.

Q1 Fiscal Year 2020

  • Comparable revenue growth of 5.5% – strong performance in Imaging with 6.7% growth and very strong in Advanced Thera-pies with 9.5% increase
  • Equipment book-to-bill of 1.2, the seventh consecutive quarter with book-to-bill >1
  • Adjusted EBIT margin of 13.5% down on previous year, negatively impacted by temporary dip in Imaging and the margin de-velopment as guided in Diagnostics
  • Adjusted basic earnings per share at €0.35
  • Free cash flow of €244 million significantly above prior year
  • Outlook for fiscal year 2020 confirmed

Bernd Montag, CEO of Siemens Healthineers AG:
»We started the new fiscal year and the Upgrading phase of our Strategy 2025 with a growth-intensive first quarter. Profitability was held back by temporary effects. Recent major order wins underline the fact that we are more than ever before the preferred partner for efficient and high-quality healthcare. Against the background of our very strong order situation, we are confident for the further development of the current fiscal year.«


As of beginning of fiscal year 2020, Siemens Healthineers applies the accounting standard IFRS 16, Leases. Comparative figures for the preceding fiscal year were not adjusted. Instead, the overall insignificant transition effects were recognized in equity as of October 1, 2019.


Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion. Further information is available at www.siemens-healthineers.com.

This document contains statements related to our future business and financial performance and future events or developments involving Siemens Healthineers that may constitute forward-looking statements. These statements may be identified by words such as “expect”, “forecast”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “estimate”, “will”, “target” or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens Healthineers’ management, of which many are beyond Siemens Healthineers’ control. As they relate to future events or developments, these statements are subject to a number of risks, uncertainties and factors, including, but not limited to those described in the respective disclosures. Should one or more of these risks, uncertainties or factors materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Siemens Healthineers may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. All forward-looking statements only speak as of the date when they were made and Siemens Healthineers neither intends, nor assumes any obligation, unless required by law, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This document includes – in the applicable financial reporting framework not clearly defined – supplemental financial measures (financial key performance indicators) that are or may be alternative performance measures (non-GAAP-measures). These supplemental financial measures may have limitations as analytical tools and should not be viewed in isolation or as alternatives to measures of Siemens Healthineers’ net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently, which may therefore not be comparable.

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

This document is an English language translation of the German document. In case of discrepancies, the German language document is the sole authoritative and universally valid version.

The information contained in this document is provided as of the date of its publication and is subject to change without notice.

Please find further explanations to our financial key performance indicators in chapter „A.2 Financial performance system“ and in the notes to the consolidated financial statements note 29 „Segment information“ in the Annual Report 2019 of Siemens Healthineers under the following internet link https://www.corporate.siemens-healthineers.com/investor-relations/presentations-financial-publications.


Contact

Stefan Schmidt
Karlheinz Kaske Straße 5
91052 Erlangen
Germany 

+49 152 02307361
stefanssschmidt@siemens-healthineers.com

Philipp Grontzki
Karlheinz Kaske Straße 5
91052 Erlangen
Germany 

+49 152 03350194
philipp.grontzki@siemens-healthineers.com